Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

ClinicalTrials.gov ID: NCT06052059

Public ClinicalTrials.gov record NCT06052059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the Modified Mayo Score at Week 12, and that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the Modified Mayo Score at week 52. Study 2's primary hypothesis is that at least 1 tulisokibart dose level is superior to Placebo in the proportion of participants achieving clinical remission according to the Modified Mayo Score at Week 12.

Study identification

NCT ID
NCT06052059
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
1,020 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2023
Primary completion
Jul 31, 2026
Completion
Jul 31, 2029
Last update posted
Mar 12, 2026

2023 – 2029

United States locations

U.S. sites
76
U.S. states
28
U.S. cities
68
Facility City State ZIP Site status
Digestive Health Specialists ( Site 0135) Dothan Alabama 36301
IMC-Gulf Coast Gastroenterology ( Site 0157) Fairhope Alabama 36532
Research Solutions of Arizona ( Site 3816) Litchfield Park Arizona 85340
One of a Kind Clinical Research Center ( Site 3852) Scottsdale Arizona 85258
GI Alliance - Sun City ( Site 0103) Sun City Arizona 85351
Clinnova Research ( Site 3803) Anaheim California 92805
Southern California Research Center ( Site 3828) Coronado California 92118
UCSD - Altman Clinical and Translational Research Institute (ACTRI) ( Site 0113) La Jolla California 92037
Cedars-Sinai Medical Center ( Site 0119) Los Angeles California 90048
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 3851) Orange California 92868
University of Colorado Anschutz Medical Campus-Division of Gastroenterology and Hepatology ( Site 0172) Aurora Colorado 80045
Peak Gastroenterology Associates ( Site 0116) Colorado Springs Colorado 80907
South Denver Gastroenterology, PC ( Site 3849) Englewood Colorado 80113
Rocky Mountain Gastroenterology/Topography Health ( Site 3838) Littleton Colorado 80120
Connecticut Clinical Research Institute ( Site 0126) Bristol Connecticut 06010
Medical Research Center of Connecticut ( Site 0151) Hamden Connecticut 06518
Yale University School of Medicine-Digestive Disease ( Site 0163) New Haven Connecticut 06510
Emerson Clinical Research Institute ( Site 3820) Washington D.C. District of Columbia 20009
Gastroenterology Consultants of Clearwater ( Site 0152) Clearwater Florida 33756
University of Florida College of Medicine-Gastroenterology ( Site 3821) Gainesville Florida 32610
Nature Coast Clinical Research - Inverness ( Site 3806) Inverness Florida 34452
Central Florida Gastro Research ( Site 0124) Kissimmee Florida 34741
Research Associates of South Florida - Miami - Southwest 8th Street ( Site 3810) Miami Florida 33134
Orlando Health ( Site 0145) Orlando Florida 32806
USF Health ( Site 0169) Tampa Florida 33612
Emory University School of Medicine ( Site 3818) Atlanta Georgia 30322
Atlanta Gastroenterology Associates - Peachtree Dunwoody ( Site 0115) Atlanta Georgia 30342
Atlanta Center for Gastroenterology ( Site 0155) Decatur Georgia 30033
University of Chicago Medical Center ( Site 0134) Chicago Illinois 60637
GI Alliance - Glenview ( Site 0168) Glenview Illinois 60026
GI ALLIANCE - GURNEE ( Site 0107) Gurnee Illinois 60031
Iowa Digestive Disease Center ( Site 0123) Clive Iowa 50325
University of Louisville Hospital-Clinical Trials Unit ( Site 0165) Louisville Kentucky 40202
Baton Rouge General Medical Center - Bluebonnet ( Site 0112) Baton Rouge Louisiana 70809
Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 0154) New Orleans Louisiana 70112
Walter Reed National Military Medical Center ( Site 0121) Bethesda Maryland 20889
Woodholme Gastroenterology Associates-Woodholme Gastroenterology Associates ( Site 3835) Glen Burnie Maryland 21061
Massachusetts General Hospital-Crohn's and Colitis Center ( Site 0132) Boston Massachusetts 02114
University of Michigan ( Site 0143) Ann Arbor Michigan 48109
Clinical Research Institute of Michigan, LLC ( Site 0108) Clinton Township Michigan 48038
Michigan Center of Medical Research (MICHMER) ( Site 3850) Farmington Hills Michigan 48334
Clinical Research Institute of Michigan, LLC ( Site 0150) Troy Michigan 48098
Huron Gastroenterology ( Site 3836) Ypsilanti Michigan 48197
Mayo Clinic in Rochester, Minnesota ( Site 0147) Rochester Minnesota 55905
BVL Research - Kansas ( Site 3847) Liberty Missouri 64068
Washington University School of Medicine ( Site 0129) St Louis Missouri 63110
Circuit Clinical /Middletown Medical PC ( Site 3831) Middletown New York 10940
NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 3846) New York New York 10016
Lenox Hill Hospital ( Site 0128) New York New York 10075
New York Gastroenterology Associates ( Site 0159) New York New York 10128
University of North Carolina Medical Center ( Site 0140) Chapel Hill North Carolina 27514
Carolina Digestive Diseases and Endoscopy Center ( Site 3809) Greenville North Carolina 27834
Hospital of the University of Pennsylvania ( Site 0170) Philadelphia Pennsylvania 19104
University Gastroenterology ( Site 0164) Providence Rhode Island 02904
Gastroenterology Associates of Orangeburg ( Site 0149) Orangeburg South Carolina 29118
Vanderbilt Inflammatory Bowel Disease Clinic ( Site 0131) Nashville Tennessee 37204
Quality Medical Research ( Site 3807) Nashville Tennessee 37211
GI Alliance - Garland ( Site 0109) Garland Texas 75044
Baylor College of Medicine Medical Center ( Site 3812) Houston Texas 77030
The University of Texas Health Science Center at Houston-Internal Medicine-Division of Gastroentero ( Site 0144) Houston Texas 77030
Clinical Trial Network ( Site 3819) Houston Texas 77074
GI Alliance - Lubbock ( Site 0167) Lubbock Texas 79410
Caprock Gastro Research ( Site 0101) Lubbock Texas 79424
GI Alliance: Mansfield ( Site 0161) Mansfield Texas 76063
CARTA - Clinical Associates In Research Therapeutics Of America ( Site 0122) San Antonio Texas 78212
Southern Star Research Institute ( Site 0106) San Antonio Texas 78229
GI Alliance - San Marcos ( Site 0130) San Marcos Texas 78666
GI Alliance - Southlake ( Site 0104) Southlake Texas 76092-9167
Tyler Research Institute ( Site 0105) Tyler Texas 75701
Texas Digestive Disease Consultants ( Site 0136) Webster Texas 77598
Velocity Clinical Research, Salt Lake City ( Site 3801) West Jordan Utah 84088
Richmond VA Medical Center ( Site 3845) Richmond Virginia 23249
Washington Gastroenterology - Bellevue ( Site 3844) Bellevue Washington 98004-4631
University of Washington Medical Center - Montlake ( Site 0137) Seattle Washington 98195
Washington Gastroenterology - Tacoma ( Site 0102) Tacoma Washington 98405
Medical College of Wisconsin ( Site 0141) Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 400 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06052059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06052059 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →